Talia Mayerson, MSc
Postgraduate AssociateCards
About
Research
Publications
2023
Discriminating cocaine use from other sympathomimetics using wearable electrocardiographic (ECG) sensors
Angarita G, Pittman B, Nararajan A, Mayerson T, Parate A, Marlin B, Gueorguieva R, Potenza M, Ganesan D, Malison R. Discriminating cocaine use from other sympathomimetics using wearable electrocardiographic (ECG) sensors. Drug And Alcohol Dependence 2023, 250: 110898. PMID: 37523916, PMCID: PMC10905422, DOI: 10.1016/j.drugalcdep.2023.110898.Peer-Reviewed Original Research
2022
Novel pharmacological agents for the treatment of cocaine use disorder.
Hadizadeh, H., Flores, J., Nunes, E., Mayerson, T., Potenza, M. N., & Angarita, G. A. (2022). Novel pharmacological agents for the treatment of cocaine use disorder. Current Behavioral Neuroscience Reports, 9(1), 27–46.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsGlutamatergic agents for the treatment of cocaine use disorder.
Hadizadeh, H., Flores, J., Nunes, E., Mayerson, T., Potenza, M. N., & Angarita, G. A. (2022). Glutamatergic agents for the treatment of cocaine use disorder. Current Behavioral Neuroscience Reports.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements